Title: The effects of liraglutide in mice with diet-induced obesity studied by metabolomics
Authors: Bugáňová, Martina
Pelantová, Helena
Holubová, Martina
Šedivá, Blanka
Maletínská, Lenka
Železná, Blanka
Kuneš, Jaroslav
Kačer, Petr
Kuzma, Marek
Haluzík, Martin
Citation: BUGÁŇOVÁ, M., PELANTOVÁ, H., HOLUBOVÁ, M., ŠEDIVÁ, B., MALETÍNSKÁ, L., ŽELEZNÁ, B., KUNEŠ, J., KAČER, P., KUZMA, M., HALUZÍK, M. The effects of liraglutide in mice with diet-induced obesity studied by metabolomics. Journal of endocrinology, 2017, roč. 233, č. 1, s. 93-104. ISSN 0022-0795.
Issue Date: 2017
Publisher: BioScientifica
Document type: článek
URI: http://hdl.handle.net/11025/29185
ISSN: 0022-0795
Keywords: NMR metabolomika;liraglutid;obezita;diabetes mellitus 2. typu;moč
Keywords in different language: NMR metabolomics;liraglutide;mouse urine;obesity;type 2 diabetes mellitus
Abstract in different language: Liraglutide is the glucagon-like peptide-1 receptor agonist widely used for the treatment of type 2 diabetes mellitus. Recently, it has been demonstrated to decrease cardiovascular morbidity and mortality in patients with type 2 diabetes and high cardiovascular risk. Although the major modes of liraglutide action are well-known, its detailed action at the metabolic level has not been studied. To this end, we explored the effect of 2-week liraglutide treatment in C57BL/6 male mice with obesity and diabetes induced by 13 weeks of high-fat diet using NMR spectroscopy to capture the changes in urine metabolic profile induced by the therapy. The liraglutide treatment decreased body and fat pads weight along with blood glucose and triglyceride levels. NMR spectroscopy identified 11 metabolites significantly affected by liraglutide treatment as compared to high-fat diet-fed control group. These metabolites included ones involved in nicotinamide adenine dinucleotide metabolism, β-oxidation of fatty acids and microbiome changes. Although majority of the metabolites changed after liraglutide treatment were similar as the ones previously identified after vildagliptin administration in a similar mouse model, the changes in creatinine, taurine and trigonelline were specific for liraglutide administration. The significance of these changes and its possible use in the personalization of antidiabetic therapy in humans requires further research.
Rights: Plný text není přístupný.
© BioScientifica
Appears in Collections:Články / Articles (KMA)

Files in This Item:
File SizeFormat 
JOE160478-1.pdf1,5 MBAdobe PDFView/Open    Request a copy

Please use this identifier to cite or link to this item: http://hdl.handle.net/11025/29185

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  1. DSpace at University of West Bohemia
  2. Publikační činnost / Publications
  3. OBD